Previous 10 | Next 10 |
home / stock / rxrx / rxrx articles
Nvidia Corp. (NASDAQ:NVDA), the posterchild of the AI revolution, did not just capitalize on the rising demand for its AI accelerators but has also...
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to industr...
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. Bumble reported quarterly los...
Shares of Beyond Meat, Inc. (NASDAQ: BYND) rose sharply in today’s pre-market trading as the company reported stronger-than-expected sales ...
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Wednesday. Shares of 3D Systems Corporation...
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading lower after the market close on Tuesday following the company’s quarterly resu...
Shares of NVIDIA Corp (NASDAQ:NVDA) rose over 15% on Thursday after the company reported quarterly earnings that beat even the most optimistic fore...
Shares of Etsy, Inc. (NASDAQ: ETSY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial result...
NVIDIA Corporation (NASDAQ: NVDA) is expected to release earnings results for its fourth quarter, after the closing bell on Feb. 21, 2024. Analysts...
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,...